{"database": "openregs", "table": "dockets", "rows": [["FDA-2004-D-0045", "FDA", "Waivers of In Vivo Demonstration of Bioequivalence of Animal Drugs in Soluble Powder Oral Dosage Form Products and Type A Medicated Articles", "Nonrulemaking", "2021-09-01T01:02:09Z", "0b0000648046e844"]], "columns": ["id", "agency_id", "title", "docket_type", "last_modified", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2004-D-0045"], "units": {}, "query_ms": 0.3225761465728283, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}